nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A4—bone cancer	0.619	1	CbGaD
Zaleplon—AOX1—Methotrexate—bone cancer	0.147	0.943	CbGbCtD
Zaleplon—CYP3A4—Doxorubicin—bone cancer	0.00897	0.0574	CbGbCtD
Zaleplon—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000338	0.0015	CcSEcCtD
Zaleplon—Hypotension—Cisplatin—bone cancer	0.000336	0.00149	CcSEcCtD
Zaleplon—Face oedema—Doxorubicin—bone cancer	0.000335	0.00149	CcSEcCtD
Zaleplon—Gastritis—Epirubicin—bone cancer	0.000332	0.00148	CcSEcCtD
Zaleplon—Muscular weakness—Epirubicin—bone cancer	0.000331	0.00147	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000331	0.00147	CcSEcCtD
Zaleplon—Mood swings—Doxorubicin—bone cancer	0.000329	0.00146	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000327	0.00146	CcSEcCtD
Zaleplon—Ataxia—Doxorubicin—bone cancer	0.000327	0.00145	CcSEcCtD
Zaleplon—Dysphagia—Epirubicin—bone cancer	0.000324	0.00144	CcSEcCtD
Zaleplon—Asthma—Epirubicin—bone cancer	0.000324	0.00144	CcSEcCtD
Zaleplon—Dysuria—Methotrexate—bone cancer	0.000324	0.00144	CcSEcCtD
Zaleplon—Paraesthesia—Cisplatin—bone cancer	0.000323	0.00144	CcSEcCtD
Zaleplon—Eosinophilia—Epirubicin—bone cancer	0.000321	0.00143	CcSEcCtD
Zaleplon—Liver function test abnormal—Doxorubicin—bone cancer	0.000321	0.00143	CcSEcCtD
Zaleplon—Dyspnoea—Cisplatin—bone cancer	0.00032	0.00142	CcSEcCtD
Zaleplon—Erectile dysfunction—Methotrexate—bone cancer	0.000319	0.00142	CcSEcCtD
Zaleplon—Dry skin—Doxorubicin—bone cancer	0.000318	0.00142	CcSEcCtD
Zaleplon—Orthostatic hypotension—Doxorubicin—bone cancer	0.000317	0.00141	CcSEcCtD
Zaleplon—Photosensitivity reaction—Methotrexate—bone cancer	0.000316	0.00141	CcSEcCtD
Zaleplon—Angina pectoris—Epirubicin—bone cancer	0.000316	0.00141	CcSEcCtD
Zaleplon—Breast disorder—Doxorubicin—bone cancer	0.000314	0.0014	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000313	0.00139	CcSEcCtD
Zaleplon—Decreased appetite—Cisplatin—bone cancer	0.000312	0.00139	CcSEcCtD
Zaleplon—Bronchitis—Epirubicin—bone cancer	0.000312	0.00139	CcSEcCtD
Zaleplon—Pneumonia—Methotrexate—bone cancer	0.000311	0.00138	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Cisplatin—bone cancer	0.00031	0.00138	CcSEcCtD
Zaleplon—Depression—Methotrexate—bone cancer	0.000308	0.00137	CcSEcCtD
Zaleplon—Gastritis—Doxorubicin—bone cancer	0.000307	0.00137	CcSEcCtD
Zaleplon—Pain—Cisplatin—bone cancer	0.000307	0.00137	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000306	0.00136	CcSEcCtD
Zaleplon—Muscular weakness—Doxorubicin—bone cancer	0.000306	0.00136	CcSEcCtD
Zaleplon—Dysuria—Epirubicin—bone cancer	0.000303	0.00135	CcSEcCtD
Zaleplon—Stomatitis—Methotrexate—bone cancer	0.000301	0.00134	CcSEcCtD
Zaleplon—Conjunctivitis—Methotrexate—bone cancer	0.0003	0.00134	CcSEcCtD
Zaleplon—Asthma—Doxorubicin—bone cancer	0.0003	0.00134	CcSEcCtD
Zaleplon—Dysphagia—Doxorubicin—bone cancer	0.0003	0.00134	CcSEcCtD
Zaleplon—Pollakiuria—Epirubicin—bone cancer	0.0003	0.00133	CcSEcCtD
Zaleplon—Eosinophilia—Doxorubicin—bone cancer	0.000297	0.00132	CcSEcCtD
Zaleplon—Sweating—Methotrexate—bone cancer	0.000296	0.00132	CcSEcCtD
Zaleplon—Photosensitivity reaction—Epirubicin—bone cancer	0.000296	0.00132	CcSEcCtD
Zaleplon—Feeling abnormal—Cisplatin—bone cancer	0.000296	0.00132	CcSEcCtD
Zaleplon—Weight increased—Epirubicin—bone cancer	0.000295	0.00131	CcSEcCtD
Zaleplon—Haematuria—Methotrexate—bone cancer	0.000295	0.00131	CcSEcCtD
Zaleplon—Weight decreased—Epirubicin—bone cancer	0.000294	0.00131	CcSEcCtD
Zaleplon—Hyperglycaemia—Epirubicin—bone cancer	0.000293	0.0013	CcSEcCtD
Zaleplon—Angina pectoris—Doxorubicin—bone cancer	0.000292	0.0013	CcSEcCtD
Zaleplon—Hepatobiliary disease—Methotrexate—bone cancer	0.000292	0.0013	CcSEcCtD
Zaleplon—Epistaxis—Methotrexate—bone cancer	0.000292	0.0013	CcSEcCtD
Zaleplon—Pneumonia—Epirubicin—bone cancer	0.000291	0.00129	CcSEcCtD
Zaleplon—Bronchitis—Doxorubicin—bone cancer	0.000289	0.00128	CcSEcCtD
Zaleplon—Body temperature increased—Cisplatin—bone cancer	0.000284	0.00126	CcSEcCtD
Zaleplon—Neuropathy peripheral—Epirubicin—bone cancer	0.000284	0.00126	CcSEcCtD
Zaleplon—Stomatitis—Epirubicin—bone cancer	0.000282	0.00125	CcSEcCtD
Zaleplon—Conjunctivitis—Epirubicin—bone cancer	0.000281	0.00125	CcSEcCtD
Zaleplon—Dysuria—Doxorubicin—bone cancer	0.000281	0.00125	CcSEcCtD
Zaleplon—Sweating—Epirubicin—bone cancer	0.000277	0.00123	CcSEcCtD
Zaleplon—Pollakiuria—Doxorubicin—bone cancer	0.000277	0.00123	CcSEcCtD
Zaleplon—Haematuria—Epirubicin—bone cancer	0.000276	0.00123	CcSEcCtD
Zaleplon—Photosensitivity reaction—Doxorubicin—bone cancer	0.000274	0.00122	CcSEcCtD
Zaleplon—Hepatobiliary disease—Epirubicin—bone cancer	0.000274	0.00122	CcSEcCtD
Zaleplon—Weight increased—Doxorubicin—bone cancer	0.000273	0.00122	CcSEcCtD
Zaleplon—Epistaxis—Epirubicin—bone cancer	0.000273	0.00121	CcSEcCtD
Zaleplon—Weight decreased—Doxorubicin—bone cancer	0.000272	0.00121	CcSEcCtD
Zaleplon—Hyperglycaemia—Doxorubicin—bone cancer	0.000271	0.0012	CcSEcCtD
Zaleplon—Pneumonia—Doxorubicin—bone cancer	0.000269	0.0012	CcSEcCtD
Zaleplon—Visual impairment—Methotrexate—bone cancer	0.000267	0.00119	CcSEcCtD
Zaleplon—Neuropathy peripheral—Doxorubicin—bone cancer	0.000262	0.00117	CcSEcCtD
Zaleplon—Stomatitis—Doxorubicin—bone cancer	0.000261	0.00116	CcSEcCtD
Zaleplon—Conjunctivitis—Doxorubicin—bone cancer	0.00026	0.00116	CcSEcCtD
Zaleplon—Eye disorder—Methotrexate—bone cancer	0.000259	0.00115	CcSEcCtD
Zaleplon—Tinnitus—Methotrexate—bone cancer	0.000259	0.00115	CcSEcCtD
Zaleplon—Hypoaesthesia—Epirubicin—bone cancer	0.000258	0.00115	CcSEcCtD
Zaleplon—Asthenia—Cisplatin—bone cancer	0.000258	0.00115	CcSEcCtD
Zaleplon—Sweating—Doxorubicin—bone cancer	0.000257	0.00114	CcSEcCtD
Zaleplon—Oedema peripheral—Epirubicin—bone cancer	0.000256	0.00114	CcSEcCtD
Zaleplon—Haematuria—Doxorubicin—bone cancer	0.000255	0.00114	CcSEcCtD
Zaleplon—Hepatobiliary disease—Doxorubicin—bone cancer	0.000253	0.00113	CcSEcCtD
Zaleplon—Epistaxis—Doxorubicin—bone cancer	0.000252	0.00112	CcSEcCtD
Zaleplon—Immune system disorder—Methotrexate—bone cancer	0.000251	0.00112	CcSEcCtD
Zaleplon—Visual impairment—Epirubicin—bone cancer	0.00025	0.00111	CcSEcCtD
Zaleplon—Chills—Methotrexate—bone cancer	0.000249	0.00111	CcSEcCtD
Zaleplon—Alopecia—Methotrexate—bone cancer	0.000245	0.00109	CcSEcCtD
Zaleplon—Mental disorder—Methotrexate—bone cancer	0.000243	0.00108	CcSEcCtD
Zaleplon—Eye disorder—Epirubicin—bone cancer	0.000243	0.00108	CcSEcCtD
Zaleplon—Tinnitus—Epirubicin—bone cancer	0.000242	0.00108	CcSEcCtD
Zaleplon—Malnutrition—Methotrexate—bone cancer	0.000242	0.00107	CcSEcCtD
Zaleplon—Hypoaesthesia—Doxorubicin—bone cancer	0.000239	0.00106	CcSEcCtD
Zaleplon—Oedema peripheral—Doxorubicin—bone cancer	0.000237	0.00105	CcSEcCtD
Zaleplon—Dysgeusia—Methotrexate—bone cancer	0.000237	0.00105	CcSEcCtD
Zaleplon—Immune system disorder—Epirubicin—bone cancer	0.000235	0.00104	CcSEcCtD
Zaleplon—Back pain—Methotrexate—bone cancer	0.000234	0.00104	CcSEcCtD
Zaleplon—Chills—Epirubicin—bone cancer	0.000233	0.00104	CcSEcCtD
Zaleplon—Visual impairment—Doxorubicin—bone cancer	0.000232	0.00103	CcSEcCtD
Zaleplon—Alopecia—Epirubicin—bone cancer	0.000229	0.00102	CcSEcCtD
Zaleplon—Mental disorder—Epirubicin—bone cancer	0.000228	0.00101	CcSEcCtD
Zaleplon—Rash—Cisplatin—bone cancer	0.000227	0.00101	CcSEcCtD
Zaleplon—Dermatitis—Cisplatin—bone cancer	0.000226	0.00101	CcSEcCtD
Zaleplon—Malnutrition—Epirubicin—bone cancer	0.000226	0.00101	CcSEcCtD
Zaleplon—Eye disorder—Doxorubicin—bone cancer	0.000225	0.000999	CcSEcCtD
Zaleplon—Ill-defined disorder—Methotrexate—bone cancer	0.000224	0.000997	CcSEcCtD
Zaleplon—Tinnitus—Doxorubicin—bone cancer	0.000224	0.000997	CcSEcCtD
Zaleplon—Anaemia—Methotrexate—bone cancer	0.000223	0.000993	CcSEcCtD
Zaleplon—Flatulence—Epirubicin—bone cancer	0.000223	0.000991	CcSEcCtD
Zaleplon—Tension—Epirubicin—bone cancer	0.000222	0.000987	CcSEcCtD
Zaleplon—Dysgeusia—Epirubicin—bone cancer	0.000221	0.000985	CcSEcCtD
Zaleplon—Nervousness—Epirubicin—bone cancer	0.00022	0.000977	CcSEcCtD
Zaleplon—Back pain—Epirubicin—bone cancer	0.000219	0.000973	CcSEcCtD
Zaleplon—Malaise—Methotrexate—bone cancer	0.000218	0.000969	CcSEcCtD
Zaleplon—Immune system disorder—Doxorubicin—bone cancer	0.000217	0.000966	CcSEcCtD
Zaleplon—Vertigo—Methotrexate—bone cancer	0.000217	0.000966	CcSEcCtD
Zaleplon—Chills—Doxorubicin—bone cancer	0.000216	0.000959	CcSEcCtD
Zaleplon—Nausea—Cisplatin—bone cancer	0.000213	0.000949	CcSEcCtD
Zaleplon—Alopecia—Doxorubicin—bone cancer	0.000212	0.000945	CcSEcCtD
Zaleplon—Mental disorder—Doxorubicin—bone cancer	0.000211	0.000937	CcSEcCtD
Zaleplon—Ill-defined disorder—Epirubicin—bone cancer	0.00021	0.000933	CcSEcCtD
Zaleplon—Malnutrition—Doxorubicin—bone cancer	0.000209	0.000931	CcSEcCtD
Zaleplon—Anaemia—Epirubicin—bone cancer	0.000209	0.00093	CcSEcCtD
Zaleplon—Agitation—Epirubicin—bone cancer	0.000208	0.000924	CcSEcCtD
Zaleplon—Flatulence—Doxorubicin—bone cancer	0.000206	0.000917	CcSEcCtD
Zaleplon—Chest pain—Methotrexate—bone cancer	0.000206	0.000915	CcSEcCtD
Zaleplon—Myalgia—Methotrexate—bone cancer	0.000206	0.000915	CcSEcCtD
Zaleplon—Arthralgia—Methotrexate—bone cancer	0.000206	0.000915	CcSEcCtD
Zaleplon—Tension—Doxorubicin—bone cancer	0.000205	0.000913	CcSEcCtD
Zaleplon—Dysgeusia—Doxorubicin—bone cancer	0.000205	0.000911	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000204	0.000909	CcSEcCtD
Zaleplon—Malaise—Epirubicin—bone cancer	0.000204	0.000907	CcSEcCtD
Zaleplon—Discomfort—Methotrexate—bone cancer	0.000203	0.000904	CcSEcCtD
Zaleplon—Nervousness—Doxorubicin—bone cancer	0.000203	0.000904	CcSEcCtD
Zaleplon—Vertigo—Epirubicin—bone cancer	0.000203	0.000904	CcSEcCtD
Zaleplon—Syncope—Epirubicin—bone cancer	0.000203	0.000902	CcSEcCtD
Zaleplon—Back pain—Doxorubicin—bone cancer	0.000202	0.0009	CcSEcCtD
Zaleplon—Palpitations—Epirubicin—bone cancer	0.0002	0.000889	CcSEcCtD
Zaleplon—Confusional state—Methotrexate—bone cancer	0.000199	0.000884	CcSEcCtD
Zaleplon—Loss of consciousness—Epirubicin—bone cancer	0.000199	0.000884	CcSEcCtD
Zaleplon—Anaphylactic shock—Methotrexate—bone cancer	0.000197	0.000877	CcSEcCtD
Zaleplon—Hypertension—Epirubicin—bone cancer	0.000195	0.000868	CcSEcCtD
Zaleplon—Ill-defined disorder—Doxorubicin—bone cancer	0.000194	0.000863	CcSEcCtD
Zaleplon—Nervous system disorder—Methotrexate—bone cancer	0.000193	0.00086	CcSEcCtD
Zaleplon—Anaemia—Doxorubicin—bone cancer	0.000193	0.00086	CcSEcCtD
Zaleplon—Arthralgia—Epirubicin—bone cancer	0.000192	0.000856	CcSEcCtD
Zaleplon—Chest pain—Epirubicin—bone cancer	0.000192	0.000856	CcSEcCtD
Zaleplon—Myalgia—Epirubicin—bone cancer	0.000192	0.000856	CcSEcCtD
Zaleplon—Agitation—Doxorubicin—bone cancer	0.000192	0.000855	CcSEcCtD
Zaleplon—Anxiety—Epirubicin—bone cancer	0.000192	0.000853	CcSEcCtD
Zaleplon—Skin disorder—Methotrexate—bone cancer	0.000191	0.000852	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000191	0.00085	CcSEcCtD
Zaleplon—Hyperhidrosis—Methotrexate—bone cancer	0.000191	0.000848	CcSEcCtD
Zaleplon—Discomfort—Epirubicin—bone cancer	0.00019	0.000846	CcSEcCtD
Zaleplon—Malaise—Doxorubicin—bone cancer	0.000189	0.000839	CcSEcCtD
Zaleplon—Dry mouth—Epirubicin—bone cancer	0.000188	0.000837	CcSEcCtD
Zaleplon—Vertigo—Doxorubicin—bone cancer	0.000188	0.000836	CcSEcCtD
Zaleplon—Anorexia—Methotrexate—bone cancer	0.000188	0.000836	CcSEcCtD
Zaleplon—Syncope—Doxorubicin—bone cancer	0.000188	0.000834	CcSEcCtD
Zaleplon—Confusional state—Epirubicin—bone cancer	0.000186	0.000828	CcSEcCtD
Zaleplon—Palpitations—Doxorubicin—bone cancer	0.000185	0.000822	CcSEcCtD
Zaleplon—Oedema—Epirubicin—bone cancer	0.000184	0.000821	CcSEcCtD
Zaleplon—Anaphylactic shock—Epirubicin—bone cancer	0.000184	0.000821	CcSEcCtD
Zaleplon—Hypotension—Methotrexate—bone cancer	0.000184	0.00082	CcSEcCtD
Zaleplon—Loss of consciousness—Doxorubicin—bone cancer	0.000184	0.000818	CcSEcCtD
Zaleplon—Shock—Epirubicin—bone cancer	0.000182	0.000808	CcSEcCtD
Zaleplon—Nervous system disorder—Epirubicin—bone cancer	0.000181	0.000805	CcSEcCtD
Zaleplon—Hypertension—Doxorubicin—bone cancer	0.000181	0.000803	CcSEcCtD
Zaleplon—Tachycardia—Epirubicin—bone cancer	0.00018	0.000801	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00018	0.000799	CcSEcCtD
Zaleplon—Skin disorder—Epirubicin—bone cancer	0.000179	0.000797	CcSEcCtD
Zaleplon—Hyperhidrosis—Epirubicin—bone cancer	0.000178	0.000793	CcSEcCtD
Zaleplon—Insomnia—Methotrexate—bone cancer	0.000178	0.000793	CcSEcCtD
Zaleplon—Arthralgia—Doxorubicin—bone cancer	0.000178	0.000792	CcSEcCtD
Zaleplon—Myalgia—Doxorubicin—bone cancer	0.000178	0.000792	CcSEcCtD
Zaleplon—Chest pain—Doxorubicin—bone cancer	0.000178	0.000792	CcSEcCtD
Zaleplon—Anxiety—Doxorubicin—bone cancer	0.000177	0.000789	CcSEcCtD
Zaleplon—Paraesthesia—Methotrexate—bone cancer	0.000177	0.000788	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000177	0.000787	CcSEcCtD
Zaleplon—Discomfort—Doxorubicin—bone cancer	0.000176	0.000783	CcSEcCtD
Zaleplon—Anorexia—Epirubicin—bone cancer	0.000176	0.000782	CcSEcCtD
Zaleplon—Dyspnoea—Methotrexate—bone cancer	0.000176	0.000782	CcSEcCtD
Zaleplon—Somnolence—Methotrexate—bone cancer	0.000175	0.00078	CcSEcCtD
Zaleplon—Dry mouth—Doxorubicin—bone cancer	0.000174	0.000775	CcSEcCtD
Zaleplon—Dyspepsia—Methotrexate—bone cancer	0.000174	0.000772	CcSEcCtD
Zaleplon—Hypotension—Epirubicin—bone cancer	0.000172	0.000767	CcSEcCtD
Zaleplon—Confusional state—Doxorubicin—bone cancer	0.000172	0.000766	CcSEcCtD
Zaleplon—Decreased appetite—Methotrexate—bone cancer	0.000171	0.000762	CcSEcCtD
Zaleplon—Anaphylactic shock—Doxorubicin—bone cancer	0.000171	0.000759	CcSEcCtD
Zaleplon—Oedema—Doxorubicin—bone cancer	0.000171	0.000759	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Methotrexate—bone cancer	0.00017	0.000757	CcSEcCtD
Zaleplon—Pain—Methotrexate—bone cancer	0.000169	0.00075	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000168	0.000748	CcSEcCtD
Zaleplon—Shock—Doxorubicin—bone cancer	0.000168	0.000747	CcSEcCtD
Zaleplon—Nervous system disorder—Doxorubicin—bone cancer	0.000167	0.000745	CcSEcCtD
Zaleplon—Insomnia—Epirubicin—bone cancer	0.000167	0.000742	CcSEcCtD
Zaleplon—Tachycardia—Doxorubicin—bone cancer	0.000167	0.000741	CcSEcCtD
Zaleplon—Skin disorder—Doxorubicin—bone cancer	0.000166	0.000738	CcSEcCtD
Zaleplon—Paraesthesia—Epirubicin—bone cancer	0.000166	0.000737	CcSEcCtD
Zaleplon—Hyperhidrosis—Doxorubicin—bone cancer	0.000165	0.000734	CcSEcCtD
Zaleplon—Dyspnoea—Epirubicin—bone cancer	0.000164	0.000732	CcSEcCtD
Zaleplon—Somnolence—Epirubicin—bone cancer	0.000164	0.00073	CcSEcCtD
Zaleplon—Anorexia—Doxorubicin—bone cancer	0.000163	0.000724	CcSEcCtD
Zaleplon—Feeling abnormal—Methotrexate—bone cancer	0.000162	0.000723	CcSEcCtD
Zaleplon—Dyspepsia—Epirubicin—bone cancer	0.000162	0.000722	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methotrexate—bone cancer	0.000161	0.000717	CcSEcCtD
Zaleplon—Decreased appetite—Epirubicin—bone cancer	0.00016	0.000714	CcSEcCtD
Zaleplon—Hypotension—Doxorubicin—bone cancer	0.00016	0.00071	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Epirubicin—bone cancer	0.000159	0.000709	CcSEcCtD
Zaleplon—Constipation—Epirubicin—bone cancer	0.000158	0.000702	CcSEcCtD
Zaleplon—Pain—Epirubicin—bone cancer	0.000158	0.000702	CcSEcCtD
Zaleplon—Urticaria—Methotrexate—bone cancer	0.000157	0.000697	CcSEcCtD
Zaleplon—Abdominal pain—Methotrexate—bone cancer	0.000156	0.000693	CcSEcCtD
Zaleplon—Body temperature increased—Methotrexate—bone cancer	0.000156	0.000693	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000156	0.000692	CcSEcCtD
Zaleplon—Insomnia—Doxorubicin—bone cancer	0.000154	0.000687	CcSEcCtD
Zaleplon—Paraesthesia—Doxorubicin—bone cancer	0.000153	0.000682	CcSEcCtD
Zaleplon—Dyspnoea—Doxorubicin—bone cancer	0.000152	0.000677	CcSEcCtD
Zaleplon—Feeling abnormal—Epirubicin—bone cancer	0.000152	0.000676	CcSEcCtD
Zaleplon—Somnolence—Doxorubicin—bone cancer	0.000152	0.000675	CcSEcCtD
Zaleplon—Gastrointestinal pain—Epirubicin—bone cancer	0.000151	0.000671	CcSEcCtD
Zaleplon—Dyspepsia—Doxorubicin—bone cancer	0.00015	0.000669	CcSEcCtD
Zaleplon—Decreased appetite—Doxorubicin—bone cancer	0.000148	0.00066	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000147	0.000656	CcSEcCtD
Zaleplon—Urticaria—Epirubicin—bone cancer	0.000147	0.000652	CcSEcCtD
Zaleplon—Pain—Doxorubicin—bone cancer	0.000146	0.000649	CcSEcCtD
Zaleplon—Constipation—Doxorubicin—bone cancer	0.000146	0.000649	CcSEcCtD
Zaleplon—Abdominal pain—Epirubicin—bone cancer	0.000146	0.000649	CcSEcCtD
Zaleplon—Body temperature increased—Epirubicin—bone cancer	0.000146	0.000649	CcSEcCtD
Zaleplon—Asthenia—Methotrexate—bone cancer	0.000141	0.000629	CcSEcCtD
Zaleplon—Feeling abnormal—Doxorubicin—bone cancer	0.000141	0.000626	CcSEcCtD
Zaleplon—Gastrointestinal pain—Doxorubicin—bone cancer	0.00014	0.000621	CcSEcCtD
Zaleplon—Pruritus—Methotrexate—bone cancer	0.000139	0.000621	CcSEcCtD
Zaleplon—Urticaria—Doxorubicin—bone cancer	0.000136	0.000603	CcSEcCtD
Zaleplon—Abdominal pain—Doxorubicin—bone cancer	0.000135	0.0006	CcSEcCtD
Zaleplon—Body temperature increased—Doxorubicin—bone cancer	0.000135	0.0006	CcSEcCtD
Zaleplon—Asthenia—Epirubicin—bone cancer	0.000132	0.000589	CcSEcCtD
Zaleplon—Pruritus—Epirubicin—bone cancer	0.000131	0.000581	CcSEcCtD
Zaleplon—Dizziness—Methotrexate—bone cancer	0.00013	0.00058	CcSEcCtD
Zaleplon—Rash—Methotrexate—bone cancer	0.000124	0.000553	CcSEcCtD
Zaleplon—Dermatitis—Methotrexate—bone cancer	0.000124	0.000552	CcSEcCtD
Zaleplon—Headache—Methotrexate—bone cancer	0.000124	0.000549	CcSEcCtD
Zaleplon—Asthenia—Doxorubicin—bone cancer	0.000122	0.000545	CcSEcCtD
Zaleplon—Dizziness—Epirubicin—bone cancer	0.000122	0.000543	CcSEcCtD
Zaleplon—Pruritus—Doxorubicin—bone cancer	0.000121	0.000537	CcSEcCtD
Zaleplon—Nausea—Methotrexate—bone cancer	0.000117	0.000521	CcSEcCtD
Zaleplon—Rash—Epirubicin—bone cancer	0.000116	0.000518	CcSEcCtD
Zaleplon—Dermatitis—Epirubicin—bone cancer	0.000116	0.000517	CcSEcCtD
Zaleplon—Headache—Epirubicin—bone cancer	0.000116	0.000514	CcSEcCtD
Zaleplon—Dizziness—Doxorubicin—bone cancer	0.000113	0.000502	CcSEcCtD
Zaleplon—Nausea—Epirubicin—bone cancer	0.00011	0.000488	CcSEcCtD
Zaleplon—Rash—Doxorubicin—bone cancer	0.000108	0.000479	CcSEcCtD
Zaleplon—Dermatitis—Doxorubicin—bone cancer	0.000108	0.000478	CcSEcCtD
Zaleplon—Headache—Doxorubicin—bone cancer	0.000107	0.000476	CcSEcCtD
Zaleplon—Nausea—Doxorubicin—bone cancer	0.000101	0.000451	CcSEcCtD
